• Client Reporting Portal
  • For Managers
  • Contact Us
Xponance | Asset Management and Investment
  • Strategies
    • Multi-Manager Platform
    • Systematic Global Equities
      • Active Strategies
        • Market Plus
        • SMID Cap Core
        • Small Cap Core
      • Passive Strategies
        • S&P 500 Index Replication
        • S&P 400 Index Replication
        • Russell 1000 Index Replication
        • Russell 1000 Growth Index Replication
        • Russell 1000 Value Index Replication
        • Russell 3000 Index Replication
        • MSCI World ex US
        • MSCI USA
      • Customized Strategies
        • S&P 500 ESG Enhanced
        • S&P 500 DEI & ESG
        • S&P 500 Catholic Values
    • U.S. Fixed Income
      • Limited Duration
      • Opportunistic Core
      • Intermediate Government/Credit
    • Xponance Alts
  • Perspectives
    • Insights
    • Archives
      • Foresights
      • Global Market Outlook Reports
      • Market Insights Alerts
      • Videos And Webinars
  • News
    • Newsroom – Press Releases
    • Media Coverage
  • About Xponance®
    • Company
    • Mission
    • People
      • Executive
      • Investment Leaders
      • Portfolio Operations
      • Corporate
      • Sales & Client Service
      • Xponance Alts
      • Board of Directors
    • Careers
    • Emerging Manager Ecosystem
    • Community Engagement
Select Page

Home » XAlts Specific News

Michael A.B. Orr Joins Xponance as Managing Director & Chief Investment Officer, Alternatives

by Tina Byles Williams | Oct 17, 2022 | XAlts Specific News, Xponance® Press Release 2022, Xponance® Press Release

​Philadelphia, October 17, 2022 – Xponance, Inc., a multi-strategy investment firm, announced today that Michael A.B. Orr has joined the firm as Managing Director & Chief Investment Officer of the firm’s Alternatives subsidiary, Xponance Alts Solutions, LLC (“XAlts”).

Xponance® and Investcorp to Launch Strategic Partnership in Support of Diverse and Woman-Owned Managers

Xponance® and Investcorp to Launch Strategic Partnership in Support of Diverse and Woman-Owned Managers

by Tina Byles Williams | Apr 6, 2021 | XAlts Specific News, Xponance® Press Release 2021, Xponance® Press Release

Xponance® today announced that they are entering into a strategic partnership to collaborate on General Partnership (GP) staking and seeding interests in diverse and woman-owned alternative asset managers. This venture will build on the strengths of both …

Marquette Chester Joins Xponance to Lead Alternatives Business

Marquette Chester Joins Xponance to Lead Alternatives Business

by Tina Byles Williams | Feb 22, 2021 | XAlts Specific News, Xponance® Press Release 2021, Xponance® Press Release

Xponance, Inc., a multi-strategy investment firm, announced today that it will expand its business to include alternative capabilities for institutional and other qualified investors. The firm has hired industry veteran Marquette Chester as Senior Managing Director to lead this effort.

Refine Search:

  • Search Term

  • Author

  • Date Range

Recent Posts

  • There’s a Pony in Here Somewhere: Q1 2025 Fixed Income Update
  • The Only Certainty Is Uncertainty: Systematic Global Equities Q1 2025 Update
  • The Fraying Trans-Atlantic Alliance is Making Europe Great Again
  • The Precariat Are Still Mad! Part III – How Should Investors Play the Next 4 Years? It Depends!
  • Change at the Top: Economic and Equity Market Implications: Systematic Global Equities Q4 2024 Update

The Xponance Edge

FIS Leadership Team
The FIS Way
Macro Tactical Management

Philadelphia

Headquarters
1845 Walnut Street
Suite 800
Philadelphia PA 19103
215.567.1100

Durham, NC

2605 Meridian Parkway
Suite 105
Durham, NC 27713
919.688.8600

Sign Up For Email Updates

Contact Us

Strategies

Multi-Manager Platform
Systematic Global Equities
U.S. Fixed Income

Perspectives

Insights
Archive Foresight
Archive Global Market Outlook Reports

News

Media Coverage
Press Releases

About Xponance®

Company
Mission
People
Emerging Manager Ecosystem
Community Engagement

Terms of Use | Privacy Policy | Careers | Form CRS | ADV Part 2A | ADV Part 2B | 408(b)(2)

  • Follow
  • Follow
  • Follow

©2006 – 2025, Xponance®, Inc. and/or its predecessor companies; XPONANCE®, TRANSFORMING ACCESS TO ALPHA and AAPRYL® are registered trademarks of Xponance®, Inc. and/or its predecessor companies. All rights reserved.